Sign in
Groups
Researchers
Results
CIRUGÍA Y SUS ESPECIALIDADES
Department
Novartis (Sweden)
Täby, Suecia
You are in
Collaborations
Novartis (Sweden)
Publications in collaboration with researchers from Novartis (Sweden) (1)
2024
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
OncoImmunology, Vol. 13, Núm. 1
Contact
Legal notice
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de